Table of Contents
Opiate Analgesic Trials and Drug Development Plans
Patient Populations for Clinical Trials of Opioids
IMS HEALTH’s National Prescription Audit PlusTM(NPA PlusTM)
Prescriptions (in thousands) and Percent Change, Opioids*, 1996 and 2000
IMS HEALTH’s National Disease and Therapeutic IndexTM (NDTITM)
Top Indication Categories for the Opioids, Totals (Mentions, in thousands), 1996 and 2000
Sample Opioid Indications
Role of Patient Populations in Clinical Trials of Opioids
Issues in Choice of Patient Populations
Duration of Treatment in Clinical Trials
Question 1
Question 2
|
Author: CDER User
|